相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer Survival
Abul Kalam Azad et al.
CLINICAL CANCER RESEARCH (2012)
Phase 1 Trial of Concurrent Erlotinib, Celecoxib, and Reirradiation for Recurrent Head and Neck Cancer
Johnny Kao et al.
CANCER (2011)
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
Tatiana Salles de Souza Malaspina et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial
Annelinde Terlou et al.
GYNECOLOGIC ONCOLOGY (2011)
Expression of the T Cell Receptor αβ on a CD123+BDCA2+HLA-DR+ Subpopulation in Head and Neck Squamous Cell Carcinoma
Annette Thiel et al.
PLOS ONE (2011)
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Jeremy D. Waight et al.
PLOS ONE (2011)
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
Antonella Sistigu et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
Camillo Porta et al.
JOURNAL OF CANCER (2011)
A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
George Fountzilas et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
HPV-induced oropharyngeal cancer, immune response and response to therapy
Ha Linh Vu et al.
CANCER LETTERS (2010)
Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung
Hannah H. Yan et al.
CANCER RESEARCH (2010)
T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
A. E. Albers et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Phase II study of sunitinib malate in head and neck squamous cell carcinoma
Nicholas W. Choong et al.
INVESTIGATIONAL NEW DRUGS (2010)
Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck
Jan Boucek et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
Jean-Pascal H. Machiels et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Head and Neck Squamous Cell Carcinoma: New Translational Therapies
Anthony Prince et al.
MOUNT SINAI JOURNAL OF MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma
Peer W. Kaemmerer et al.
ORAL ONCOLOGY (2010)
Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma
Yoshiko Watanabe et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2010)
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer-Preclinical Background: CTLA-4 and PD-1 Blockade
Jeffrey Weber
SEMINARS IN ONCOLOGY (2010)
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study
Marina T. van Leeuwen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases Acute Toxicity and Preliminary Response
Johnny Kao et al.
CANCER (2009)
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: Mechanisms of suppression and expansion in advanced disease
Christoph Bergmann et al.
CLINICAL CANCER RESEARCH (2008)
Therapeutic human papillomavirus vaccines: current clinical trials and future directions
Chien-Fu Hung et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Treatment of vulvar intraepithelial neoplasia with topical imiquimod
Manon van Seters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Farbod Shojaei et al.
NATURE (2007)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia
L. D. Roman et al.
GYNECOLOGIC ONCOLOGY (2007)
An MVA vaccine overcomes tolerance to human p53 in mice and humans
Guang-Yun Song et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
James E. Talmadge et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours
C. C. R. Ragin et al.
BRITISH JOURNAL OF CANCER (2006)
Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma
Xinhong Wang et al.
ORAL ONCOLOGY (2006)
Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma
F Tsushima et al.
ORAL ONCOLOGY (2006)
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
C Badoual et al.
CLINICAL CANCER RESEARCH (2006)
Transforming growth factor-beta in cancer and metastasis
Sonia B. Jakowlew
CANCER AND METASTASIS REVIEWS (2006)
Role of cytokines in head and neck squamous cell carcinoma
Ralph Pries et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Galectin-1: A link between tumor hypoxia and tumor immune privilege
QT Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the Janus-activated kinase 2/signal transducers and activators of transcription 3 pathway
Y Nefedova et al.
CANCER RESEARCH (2005)
Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck
LJ Wirth et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Defects in the human leukocyte antigen class I antigen-processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome
M Meissner et al.
CLINICAL CANCER RESEARCH (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Human leukocyte antigen (HLA) class I defects in head and neck cancer
RL Ferris et al.
IMMUNOLOGIC RESEARCH (2005)
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants - Common and distinctive features of biological significance
HR Choi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses
SD Wang et al.
MICROBES AND INFECTION (2004)
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity
ML Gillison
SEMINARS IN ONCOLOGY (2004)
Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization
J LeCouter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang et al.
CANCER CELL (2004)
Ifosfamide in the treatment of head and neck cancer
M Airoldi et al.
ONCOLOGY (2003)
Generation of T cells specific for the wild-type sequence p53264-272 peptide in cancer patients:: Implications for immunoselection of epitope loss variants
TK Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2000)